References
- Lemoine E, Thadhani R. Affordable preeclampsia therapeutics. Trends Pharmacol Sci. 2019;40(2):85–87.
- Jim B, Karumanchi SA. Preeclampsia: pathogenesis, prevention, and long-term complications. Semin nephrol. 2017;37(4):386-397.
- Rana S, Lemoine E, Granger J, et al. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019;124(7):1094–1112.
- Williams PJ, Pipkin FB. The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Pract Res Clin Obstetrics Gynaecol. 2011;25(4):405–417.
- Procopciuc LM, Caracostea G, Zaharie G, et al. Newborn APOE genotype influences maternal lipid profile and the severity of high-risk pregnancy–preeclampsia: interaction with maternal genotypes as a modulating risk factor in preeclampsia. Hypertens Pregnancy. 2015;34(3):271–283.
- Huang Y, Mahley RW. Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer’s diseases. Neurobiol Dis. 2014;72:3–12.
- Mahley RW, Apolipoprotein E. from cardiovascular disease to neurodegenerative disorders. J Mol Med. 2016;94(7):739–746.
- Abyadeh M, Djafarian K, Heydarinejad F, et al. Association between apolipoprotein e gene polymorphism and alzheimer’s disease in an iranian population: a meta-analysis. J Mol Neurosci. 2019;69(4):557-562.
- Nagy B, Rigo J, Fintor L, et al. Apolipoprotein E alleles in women with severe pre-eclampsia. J Clin Pathol. 1998;51(4):324–325.
- Chikosi AB, Moodley J, Moodley J, et al. Apolipoprotein E polymorphism in South African Zulu women with preeclampsia. Hypertens Pregnancy. 2000;19(3):309–314.
- Ahmadi R, Rahimi Z, Vaisi-Raygani A, et al. Apolipoprotein E genotypes, lipid peroxidation, and antioxidant status among mild and severe preeclamptic women from Western Iran: protective role of Apolipoprotein ϵ2 allele in severe preeclampsia. Hypertens Pregnancy. 2012;31(4):405–418.
- Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Jama. 2000;283(15):2008–2012.
- Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2011.
- Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, et al. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11(2):193.
- Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
- Makkonen N, Heinonen S, Hiltunen M, et al. Apolipoprotein E alleles in women with pre-eclampsia. J Clin Pathol. 2001;54(8):652–654.
- Francoual J, Audibert F, Trioche P, et al. Is a polymorphism of the apolipoprotein E gene associated with preeclampsia? Hypertens Pregnancy. 2002;21(2):127–133.
- Spracklen CN, Smith CJ, Saftlas AF, et al. Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis. Am J Epidemiol. 2014;180(4):346–358.
- Belo L, Gaffney D, Caslake M, et al. Apolipoprotein E and cholesteryl ester transfer protein polymorphisms in normal and preeclamptic pregnancies. Eur J Obstetrics Gynecol Reprod Biol. 2004;112(1):9–15.
- Bernard N, Girouard J, Forest J-C, et al. The combination of ApoCIII, hepatic lipase and hormone sensitive lipase gene polymorphisms suggests an association with susceptibility to gestational hypertension. J Hum Genet. 2007;52(3):244–254.
- Procopciuc LM, Hazi GM, Caracostea G, et al. Apolipoprotein E polymorphism-a risk factor in Romanian pregnant women with preeclampsia. Gineco Ro. 2011;7(3):134–140.
- Jamalzei B, Fallah S, Kashanian M, et al. Association of the apolipoprotein E variants with susceptibility to pregnancy with preeclampsia. Clin Lab. 2013;59(5–6):563–570.
- Parikh NI, Gonzalez J. Preeclampsia and hypertension: courting a long while: time to make it official. JAMA Intern Med. 2017;177(7):917–918.
- Niu W, Qi Y, Qian Y, et al. The relationship between apolipoprotein E ɛ2/ɛ3/ɛ4 polymorphisms and hypertension: a meta-analysis of six studies comprising 1812 cases and 1762 controls. Hypertens Res. 2009;32(12):1060.
- Shi J, Liu Y, Liu Y, et al. Association between ApoE polymorphism and hypertension: a meta-analysis of 28 studies including 5898 cases and 7518 controls. Gene. 2018;675:197–207.
- Pennington KA, Schlitt JM, Jackson DL, et al. Preeclampsia: multiple approaches for a multifactorial disease. Dis Model Mech. 2012;5(1):9–18.
- Marshall WJ, Lapsley M, Day A, Ayling R, Bayly GR. Lipids and disorders of lipoprotein metabolism. In: Clinical biochemistry: metabolic and clinical aspects. Elsevier Health Sciences; 2014. p. 702–736.
- Johnston RA, Suratt BT. Mechanisms and manifestations of obesity in lung disease. Academic Press; 2018.
- Weisgraber KH, Innerarity T, Mahley R. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem. 1982;257(5):2518–2521.
- Dong L-M, Innerarity TL, Arnold KS, et al. The carboxyl terminus in apolipoprotein E2 and the seven amino acid repeat in apolipoprotein E-Leiden: role in receptor-binding activity. J Lipid Res. 1998;39(6):1173–1180.
- Al Harthi F, Huraib GB, Zouman A, et al. Apolipoprotein E gene polymorphism and serum lipid profile in Saudi patients with psoriasis. Dis Markers. 2014;2014:1–8.
- Grant WB. A multicountry ecological study of risk-modifying factors for prostate cancer: apolipoprotein E ε4 as a risk factor and cereals as a risk reduction factor. Anticancer Res. 2010;30(1):189–199.